Norges Bank’s T2 Biosystems, Inc TTOO Stock Holding History

Norges Bank’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10	Closed	-$210K	–	2141
2017 Q3	$210K	Buy	+10	New	+$186K	﹤0.01%	2115

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank's TTOO Position: Q4 2017 in Review

Norges Bank sold out of T2 Biosystems, Inc (TTOO) in Q4 2017, closing a stake of 10 shares — an estimated $210K sold.

Norges Bank first reported a position in TTOO in Q3 2017 and held it in 1 quarter. The position peaked at $210K in Q3 2017. 35 funds tracked by Wall St. Rank hold TTOO as of Q4 2017.

Norges Bank reported no remaining T2 Biosystems, Inc position as of Q4 2017 after selling out during the quarter.
Norges Bank sold 10 T2 Biosystems, Inc shares in Q4 2017, an estimated $210K.
Norges Bank first reported a position in T2 Biosystems, Inc in Q3 2017 and held it in 1 quarter.
Norges Bank's T2 Biosystems, Inc position peaked at $210K in Q3 2017.
35 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2017.

Based on Norges Bank's 13F filing for Q4 2017, filed 9 Feb 2018.